Entia Biosciences Stock Price Prediction
| ERGO Stock | USD 0.0002 0.00 0.00% |
Oversold Vs Overbought
100
Oversold | Overbought |
Using Entia Biosciences hype-based prediction, you can estimate the value of Entia Biosciences from the perspective of Entia Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Entia Biosciences to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Entia because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Entia Biosciences after-hype prediction price | USD 1.22E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Entia |
Entia Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Entia Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Entia Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Entia Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Entia Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Entia Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Entia Biosciences' historical news coverage. Entia Biosciences' after-hype downside and upside margins for the prediction period are 0.00 and 12.50, respectively. We have considered Entia Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Entia Biosciences is out of control at this time. Analysis and calculation of next after-hype price of Entia Biosciences is based on 3 months time horizon.
Entia Biosciences Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Entia Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Entia Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Entia Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.56 | 12.50 | 0.00 | 0.02 | 0 Events / Month | 3 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0002 | 0.0001 | 39.06 |
|
Entia Biosciences Hype Timeline
Entia Biosciences is currently traded for 0.0002. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Entia is forecasted to decline in value after the next headline, with the price expected to drop to 1.22E-4. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -39.06%, whereas the daily expected return is currently at 1.56%. The volatility of related hype on Entia Biosciences is about 83333.33%, with the expected price after the next announcement by competition of 0.02. The company recorded a loss per share of 0.05. Entia Biosciences had not issued any dividends in recent years. The entity had 1:10 split on the 15th of February 2012. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Entia Biosciences Basic Forecasting Models to cross-verify your projections.Entia Biosciences Related Hype Analysis
Having access to credible news sources related to Entia Biosciences' direct competition is more important than ever and may enhance your ability to predict Entia Biosciences' future price movements. Getting to know how Entia Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Entia Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PRVCF | PreveCeutical Medical | 0.00 | 0 per month | 10.44 | 0.12 | 31.58 | (27.81) | 84.50 | |
| RSPI | RespireRx Pharmaceuticals | 0.00 | 0 per month | 12.21 | 0.08 | 34.62 | (21.57) | 76.50 | |
| IPCIF | Intellipharmaceutics International | 0.00 | 0 per month | 21.88 | 0.17 | 100.00 | (50.00) | 583.33 | |
| SCPS | Scopus Biopharma | 0.00 | 0 per month | 17.61 | 0.02 | 35.42 | (24.69) | 94.02 | |
| CNBX | Cannabics Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 42.86 | |
| HRTX | Heron Therapeuti | 0.24 | 9 per month | 6.33 | 0.0008 | 6.54 | (5.88) | 44.80 | |
| OTLK | OUTLOOK THERAPEUTICS INC | (0.05) | 9 per month | 0.00 | (0.19) | 5.88 | (9.76) | 72.39 | |
| GRTX | Galera Therapeutics | 0.00 | 0 per month | 0.00 | (0.04) | 7.31 | (5.84) | 18.16 | |
| PLX | Protalix Biotherapeutics | 0.15 | 5 per month | 2.32 | 0.19 | 8.00 | (4.92) | 21.48 | |
| HOOK | Hookipa Pharma | (0.19) | 9 per month | 0.00 | (0.32) | 6.85 | (6.67) | 22.98 |
Entia Biosciences Additional Predictive Modules
Most predictive techniques to examine Entia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Entia using various technical indicators. When you analyze Entia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Entia Biosciences Predictive Indicators
The successful prediction of Entia Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Entia Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Entia Biosciences based on analysis of Entia Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Entia Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Entia Biosciences's related companies.
Story Coverage note for Entia Biosciences
The number of cover stories for Entia Biosciences depends on current market conditions and Entia Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Entia Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Entia Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Entia Biosciences Short Properties
Entia Biosciences' future price predictability will typically decrease when Entia Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Entia Biosciences often depends not only on the future outlook of the potential Entia Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Entia Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 24.3 M | |
| Cash And Short Term Investments | 76 K |
Other Information on Investing in Entia Pink Sheet
Entia Biosciences financial ratios help investors to determine whether Entia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entia with respect to the benefits of owning Entia Biosciences security.